Connacht Asset Management’s Surgery Partners SGRY Stock Holding History

Connacht Asset Management’s Portfolio SGRY Stock Details SGRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8,117	Closed	-$365K	–	84
2023 Q2	$365K	Buy	8,117 +560	+7%	+$21.4K	0.5%	63
2023 Q1	$260K	Buy	+7,557	New	+$245K	0.11%	120
2022 Q4	–	Sell	-12,372	Closed	-$290K	–	140
2022 Q3	$290K	Buy	12,372 +2,244	+22%	+$71.7K	0.21%	101
2022 Q2	$293K	Buy	10,128 +20	+0.2%	+$874	0.12%	121
2022 Q1	$556K	Buy	10,108 +420	+4%	+$20.8K	0.28%	80
2021 Q4	$517K	Buy	9,688 +4,217	+77%	+$196K	0.5%	66
2021 Q3	$232K	Buy	5,471 +1,013	+23%	+$51.7K	0.15%	90
2021 Q2	$297K	Sell	4,458 -18,065	-80%	-$981K	0.13%	92
2021 Q1	$997K	Sell	22,523 -54,161	-71%	-$2.01M	0.22%	94
2020 Q4	$2.23M	Buy	+76,684	New	+$1.91M	1.06%	31

Other funds holding SGRY

BCI

Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Connacht Asset Management's SGRY Position: Q3 2023 in Review

Connacht Asset Management sold out of Surgery Partners (SGRY) in Q3 2023, closing a stake of 8,117 shares — an estimated $365K sold.

Connacht Asset Management first reported a position in SGRY in Q4 2020 and held it in 10 quarters. The position peaked at $2.23M in Q4 2020. 164 funds tracked by Wall St. Rank hold SGRY as of Q3 2023.

Connacht Asset Management reported no remaining Surgery Partners position as of Q3 2023 after selling out during the quarter.
Connacht Asset Management sold 8,117 Surgery Partners shares in Q3 2023, an estimated $365K.
Connacht Asset Management first reported a position in Surgery Partners in Q4 2020 and held it in 10 quarters.
Connacht Asset Management's Surgery Partners position peaked at $2.23M in Q4 2020.
164 funds tracked by Wall St. Rank held Surgery Partners as of Q3 2023.

Based on Connacht Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.